Search research articles
Contact Us
Filters
Showing results (11-20 of 140) with videos related to
Page
of 14
Sort By:
Molecular Psychiatry
|
December 2, 2022
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Andrew H Miller, Charles L Raison
Nature Reviews. Immunology
|
December 30, 2015
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H Miller, Charles L Raison
The American Journal of Psychiatry
|
August 29, 2003
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
Charles L Raison, Andrew H Miller
Biological Psychiatry
|
August 2, 2003
Depression in cancer: new developments regarding diagnosis and treatment
Charles L Raison, Andrew H Miller
Frontiers in Psychiatry
|
January 30, 2026
University student wellbeing during COVID-19: associations with infection prevalence and social gathering restrictions in an observational study
Donald J Noble, Charles L Raison
Molecular Psychiatry
|
June 23, 2023
Psychedelics and ketamine are a symptom of psychiatry's woes, not a cure
Andrew H Miller, Charles L Raison
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 19, 2006
Cytokines, p38 MAP kinase and the pathophysiology of depression
Andrew H Miller, Charles L Raison
Current Psychiatry Reports
|
September 20, 2011
Is depression an inflammatory disorder?
Charles L Raison, Andrew H Miller
Modern Trends in Pharmacopsychiatry
|
September 17, 2014
Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment
Charles L Raison, Andrew H Miller
Proceedings of the National Academy of Sciences of the United States of America
|
January 26, 2018
An evolutionary perspective on nutrition and social decision making
Charles L Raison, David A Raichlen
Page
of 14
Search research articles
Search
Showing results (11-20 of 140) with videos related to
Sort By:
Page
of 14
Molecular Psychiatry
|
December 2, 2022
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Andrew H Miller, Charles L Raison
Nature Reviews. Immunology
|
December 30, 2015
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H Miller, Charles L Raison
The American Journal of Psychiatry
|
August 29, 2003
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
Charles L Raison, Andrew H Miller
Biological Psychiatry
|
August 2, 2003
Depression in cancer: new developments regarding diagnosis and treatment
Charles L Raison, Andrew H Miller
Frontiers in Psychiatry
|
January 30, 2026
University student wellbeing during COVID-19: associations with infection prevalence and social gathering restrictions in an observational study
Donald J Noble, Charles L Raison
Molecular Psychiatry
|
June 23, 2023
Psychedelics and ketamine are a symptom of psychiatry's woes, not a cure
Andrew H Miller, Charles L Raison
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 19, 2006
Cytokines, p38 MAP kinase and the pathophysiology of depression
Andrew H Miller, Charles L Raison
Current Psychiatry Reports
|
September 20, 2011
Is depression an inflammatory disorder?
Charles L Raison, Andrew H Miller
Modern Trends in Pharmacopsychiatry
|
September 17, 2014
Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment
Charles L Raison, Andrew H Miller
Proceedings of the National Academy of Sciences of the United States of America
|
January 26, 2018
An evolutionary perspective on nutrition and social decision making
Charles L Raison, David A Raichlen
Page
of 14